UBX - Unity Biotechnology, Inc.

QQQ $ 473.14 $ -2.10 (-0.44 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.29 $ 0.92 (0.92 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 1.41

Open

$ 1.44

Bid

$ 1.40 x 200

Ask

$ 1.42 x 200

Day's Range

$ 1.40 - $ 1.44

52 Week Range

$ 1.22 - $ 2.60

Volume

23,744

Average Volume

Market Cap

23.76M

Beta (5Y Monthly)

$ 1.21

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	04-15-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-15-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-12-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-15-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-11-2021	03-31-2021	10-Q
15	03-23-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	07-31-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-11-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-06-2019	12-31-2018	10-K
24	11-07-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	06-07-2018	03-31-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Rodman & Renshaw Initiates Coverage On Uni...
08/22/2024 17:33:51

Rodman & Renshaw initiates coverage on Unity Biotechnology (NASDAQ:UBX) with a Buy rating and announces Price Target of $8.

HC Wainwright & Co. Reiterates Buy on Unit...
08/08/2024 11:27:58

HC Wainwright & Co. analyst Andrew Fein reiterates Unity Biotechnology (NASDAQ:UBX) with a Buy and maintains $8 price ta...

Unity Biotechnology Q2 2024 Adj EPS $(0.31...
08/06/2024 21:12:39

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(...

HC Wainwright & Co. Reiterates Buy on Unit...
05/15/2024 15:07:22

HC Wainwright & Co. analyst Andrew Fein reiterates Unity Biotechnology (NASDAQ:UBX) with a Buy and maintains $8 price ta...

Unity Biotechnology Q1 EPS $(0.34) Beats $...
05/14/2024 21:23:18

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(...

UNITY Biotechnology Announces Extension Of...
04/23/2024 12:02:51

Visa To Rally Around 18%? Here Are 10 Top ...
04/17/2024 12:21:44

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

HC Wainwright & Co. Maintains Buy on Unity...
04/17/2024 09:53:41

HC Wainwright & Co. analyst Andrew Fein maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and lowers the price targe...

HC Wainwright & Co. Maintains Buy on Unity...
04/16/2024 11:05:56

HC Wainwright & Co. analyst Andrew Fein maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and lowers the price targe...

Unity Biotechnology's 2023 Cash, Cash Equi...
04/15/2024 11:23:26

Unity Biotechnology Q4 2023 GAAP EPS $(0.2...
04/15/2024 11:22:04

Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
03/25/2024 21:32:19

UNITY Biotechnology, Inc. Announces New Pu...
02/06/2024 13:04:47

UNITY Biotechnology, Inc. ("UNITY") (NASDAQ:UBX), a biotechnology company developing therapeutics to slow, halt or reve...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
01/19/2024 21:31:09

UNITY Biotechnology Announced That The Fi...
12/12/2023 13:04:08

ASPIRE is a multi-center, randomized, double-masked, active-controlled study designed to evaluate the safety and efficacy of UB...

Unity Biotechnology Reports Secondary Offe...
12/06/2023 22:32:44

unity-biotechnology-upgraded---analyst-highlights-cash-strength--execution

Unity Biotechnology Upgraded - Analyst Hig...
11/16/2023 19:41:11

Wedbush analyst Andreas Argyrides upgraded the shares of Unity Biotechnology Inc (NASDAQ: UBX) from Neutral to Outperform and

Wedbush Upgrades Unity Biotechnology to Ou...
11/16/2023 13:03:19

Wedbush analyst Andreas Argyrides upgrades Unity Biotechnology (NASDAQ:UBX) from Neutral to Outperform.

HC Wainwright & Co. Reiterates Buy on Unit...
11/14/2023 12:11:33

HC Wainwright & Co. analyst Matthew Caufield reiterates Unity Biotechnology (NASDAQ:UBX) with a Buy and maintains $10 pr...

UNITY Biotechnology Q3 EPS $(1.05) vs $(1....
11/13/2023 22:18:13